Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Treatment of LRTI

Thematic Poster Session
Chairs: J. Dorca (Barcelona, Spain), G. Folkerts (Utrecht, The Netherlands)

Download all media

Comparative trial of cefuroxime 250 mg with probenecid 250 mg with cefuroxime 500 mg in lower respiratory tract infection A. A. Desai, P. P. Rao (Mumbai, India)
Efficacy and safety of oral pharmacokinetically enhanced amoxicillin/clavulanate 2000/125 mg twice daily versus oral amoxicillin/clavulanate 1000/125 mg three times daily for the treatment of bacterial community-acquired pneumonia (CAP) P. Petitpretz, C. Chidiac, F. Soriano, J. Garau, K. Stevenson, E. Rouffiac (Le Chesnay, Versailles, Lyon, Nanterre, France; Madrid, Barcelona, Spain; Harlow, United Kingdom)
*Efficacy and cost analysis of ceftriaxone 1 g versus* aminopenicillin-betalactamase inhibitors in the treatment of pneumonia on general medical wards** J. Lorenz, E. S. Dietrich, T. Detering, K. H. Kullmann, T. Welte (Lüdenscheid, Freiburg, Grenzach-Wyhlen, Magdeburg, Germany)
COPD: antibiotic strategy in infectious exacerbations A. Bugalho, L. Telo, L. Carvalho, F. Froes, C. Nunes, J. P. Mata (Lisbon, Portugal)
Effectiveness of azithromycin (AZ) in patients with community-acquired pneumonia (CAP): an evidenced-based meta-analysis of randomized controlled trials (RCTs) J. Harnett, J. Wilson (New York, United States Of America)
*Levofloxacin versus* Ciprofloxacin susceptibility of Gram negative bacteria obtained from respiratory tract specimens** R. Cosentini, F. Blasi, P. Tarsia, A. Grugnetti, V. Popescu-Janu, L. Allegra (Milano, Italy)
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease M. D. Filipovic, S. S. Pljaskic-Kamenov, S. S. Cekic (Nis, Yugoslavia)
*3x2g ceftazidime as short infusion versus* 2x2g ceftazidime as 7 hours infusion in patients with acute exacerbation of severe chronic bronchitis (AECB)** A. Lubasch, S. Lück, H. Lode, J. Lorenz, L. P. Boelskei, The Study Group (Berlin, Germany)
Aerosolized tobramycin in patients with Wegener's granulomatosis C. Terzano, V. Peona (Roma, Italy)
Therapy of pulmonary aspergillosis with newly developed azole-derivatives H. Grysczyk, A. de Roux, H. Mauch, A. Grassot, H. Lode (Berlin, Germany)
Mycoplasma pneumoniae and respiratory viruses in patients with protracted forms of acute bronchitis N. V. Yakovleva, N. A. Shkliarevich, V. P. Molodtsova, A. A. Bazhanov (Saint-Petersburg, Russia)
Clinical correlates of bronchiectasis in a Western European population A. Basu, P. A. Stockton, E. Hilal, M. J. Ledson, C. C. Evans, M. J. Walshaw (Liverpool, United Kingdom)